AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
HEPATIC-FAILURE AND LIVER-CELL DAMAGE IN ACUTE WILSONS-DISEASE INVOLVE CD95 (APO-1 FAS) MEDIATED APOPTOSIS/
Authors: STRAND S HOFMANN WJ GRAMBIHLER A HUG H VOLKMANN M OTTO G WESCH H MARIANI SM HACK V STREMMEL W KRAMMER PH GALLE PR
Citation: S. Strand et al., HEPATIC-FAILURE AND LIVER-CELL DAMAGE IN ACUTE WILSONS-DISEASE INVOLVE CD95 (APO-1 FAS) MEDIATED APOPTOSIS/, Nature medicine, 4(5), 1998, pp. 588-593
ANTI-P53 AUTOANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS (HCV) INFECTION
Authors: KALLINOWSKI B VOLKMANN M FIEHN W STREMMEL W
Citation: B. Kallinowski et al., ANTI-P53 AUTOANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS (HCV) INFECTION, Hepatology, 28(4), 1998, pp. 2110-2110
P53 DIFFERENTIALLY REGULATES CD95 RECEPTOR AND CD95 LIGAND EXPRESSIONIN HEPATOMA-CELLS IN RESPONSE TO CHEMOTHERAPEUTIC DRUGS
Authors: MUELLER M FRIDMAN SL LEHLBACH K VOLKMANN M STREMMEL W GALLE PR KRAMMER PH
Citation: M. Mueller et al., P53 DIFFERENTIALLY REGULATES CD95 RECEPTOR AND CD95 LIGAND EXPRESSIONIN HEPATOMA-CELLS IN RESPONSE TO CHEMOTHERAPEUTIC DRUGS, Hepatology, 26(4), 1997, pp. 510-510
HELICOBACTER SPP ARE NOT DETECTABLE IN HUMAN BILE AND PANCREATIC-JUICE SAMPLES
Authors: RUDI J RUDY A MAIWALD M VOLKMANN M STREMMEL W
Citation: J. Rudi et al., HELICOBACTER SPP ARE NOT DETECTABLE IN HUMAN BILE AND PANCREATIC-JUICE SAMPLES, Gastroenterology, 112(4), 1997, pp. 273-273
EFFECT OF PERSONAL HYGIENE ON BLOOD LEAD LEVELS OF WORKERS AT A LEAD PROCESSING FACILITY
Authors: ASKIN DP VOLKMANN M
Citation: Dp. Askin et M. Volkmann, EFFECT OF PERSONAL HYGIENE ON BLOOD LEAD LEVELS OF WORKERS AT A LEAD PROCESSING FACILITY, American Industrial Hygiene Association journal, 58(10), 1997, pp. 752-753
DESTRUCTION OF T-LYMPHOCYTES AND POSSIBLE IMMUNE EVASION OF CD95-LIGAND-EXPRESSING HEPATOMA-CELLS
Authors: GALLE PP STRAND S MULLER M HOFMANN WJ HUG H VOLKMANN M OTTO G KRAMMER PH STREMMEL W
Citation: Pp. Galle et al., DESTRUCTION OF T-LYMPHOCYTES AND POSSIBLE IMMUNE EVASION OF CD95-LIGAND-EXPRESSING HEPATOMA-CELLS, Hepatology, 24(4), 1996, pp. 872-872
USE OF SPECIFIC ELISA FOR THE DETECTION OF ANTIBODIES DIRECTED AGAINST P53 PROTEIN IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
Authors: RYDER SD RIZZI PM VOLKMANN M METIVIER E PEREIRA LMMB GALLE PR NAOUMOV NV ZENTGRAF H WILLIAMS R
Citation: Sd. Ryder et al., USE OF SPECIFIC ELISA FOR THE DETECTION OF ANTIBODIES DIRECTED AGAINST P53 PROTEIN IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA, Journal of Clinical Pathology, 49(4), 1996, pp. 295-299
CYSTEINE MUTATIONS IN THE MAM DOMAIN RESULT IN MONOMERIC MEPRIN AND ALTER STABILITY AND ACTIVITY OF THE PROTEINASE
Authors: MARCHAND P VOLKMANN M BOND JS
Citation: P. Marchand et al., CYSTEINE MUTATIONS IN THE MAM DOMAIN RESULT IN MONOMERIC MEPRIN AND ALTER STABILITY AND ACTIVITY OF THE PROTEINASE, The Journal of biological chemistry, 271(39), 1996, pp. 24236-24241
CHEMOTHERAPY-INDUCED P53 ACCUMULATION IN HEPG2 CELLS RESULTS IN INDUCTION OF CD95 (APO-1 FAS) RECEPTOR AND LIGAND FOLLOWED BY APOPTOSIS/
Authors: MUELLER M STRAND S HUG H HEINEMANN EM VOLKMANN M KRAMMER P STREMMEL W GALLE PR
Citation: M. Mueller et al., CHEMOTHERAPY-INDUCED P53 ACCUMULATION IN HEPG2 CELLS RESULTS IN INDUCTION OF CD95 (APO-1 FAS) RECEPTOR AND LIGAND FOLLOWED BY APOPTOSIS/, Gastroenterology, 110(4), 1996, pp. 563-563
P53 AND FAS APO-1 INDUCTION IN HEPATOMA-CELLS IN RESPONSE TO TREATMENT WITH DNA-DAMAGING AGENTS/
Authors: MUELLER M AFINIAWANI EM KRAMMER P VOLKMANN M STREMMEL W GALLE PR
Citation: M. Mueller et al., P53 AND FAS APO-1 INDUCTION IN HEPATOMA-CELLS IN RESPONSE TO TREATMENT WITH DNA-DAMAGING AGENTS/, Hepatology, 22(4), 1995, pp. 200-200
NITRIDO-SODALITES .2. SYNTHESIS, CRYSTAL- STRUCTURE AND PROPERTIES OFM(6+(Y 2)-X)H-2X[P12N24]Z(GAMMA) WITH M=FE, CO, NI, MN, Z=CL, BR, I -0-LESS-THAN-OR-EQUAL-TO-X LESS-THAN-OR-EQUAL-TO-4 - Y-LESS-THAN-OR-EQUAL-TO-2/
Authors: SCHNICK W STOCK N LUCKE J VOLKMANN M JANSEN M
Citation: W. Schnick et al., NITRIDO-SODALITES .2. SYNTHESIS, CRYSTAL- STRUCTURE AND PROPERTIES OFM(6+(Y 2)-X)H-2X[P12N24]Z(GAMMA) WITH M=FE, CO, NI, MN, Z=CL, BR, I -0-LESS-THAN-OR-EQUAL-TO-X LESS-THAN-OR-EQUAL-TO-4 - Y-LESS-THAN-OR-EQUAL-TO-2/, Zeitschrift fur anorganische und allgemeine Chemie, 621(6), 1995, pp. 987-992
HIGH PREVALENCE OF ANTIBODIES TO THE 128 KD PROTEIN (CAGA) IN SERA OFGASTRIC-CANCER PATIENTS INFECTED WITH HELICOBACTER-PYLORI
Authors: RUDI J MAIWALD M VOLKMANN M VONHERBAY A GALLE PR STREMMEL W
Citation: J. Rudi et al., HIGH PREVALENCE OF ANTIBODIES TO THE 128 KD PROTEIN (CAGA) IN SERA OFGASTRIC-CANCER PATIENTS INFECTED WITH HELICOBACTER-PYLORI, Gastroenterology, 108(4), 1995, pp. 205-205
ANTI-P53 AUTOANTIBODIES AS SEROLOGICAL MARKER IN DIFFERENT TUMOR-ENTITIES
Authors: VOLKMANN M MULLER M MEYER M ULSPERGER E LEHNERT T FIEHN W ZENTGRAF H GALLE PR
Citation: M. Volkmann et al., ANTI-P53 AUTOANTIBODIES AS SEROLOGICAL MARKER IN DIFFERENT TUMOR-ENTITIES, Clinical chemistry, 41(6), 1995, pp. 221-222
P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO THERAPY WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS
Authors: DOHNER H FISCHER K BENTZ M HANSEN K BENNER A CABOT G DIEHL D SCHLENK R COY J STILGENBAUER S VOLKMANN M GALLE PR POUSTKA A HUNSTEIN W LICHTER P
Citation: H. Dohner et al., P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO THERAPY WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS, Blood, 85(6), 1995, pp. 1580-1589
P53 OVEREXPRESSION IS FREQUENT IN EUROPEAN HEPATOCELLULAR-CARCINOMA AND LARGELY INDEPENDENT OF THE CODON-249 HOT-SPOT MUTATION
Authors: VOLKMANN M HOFMANN WJ MULLER M RATH U OTTO G ZENTGRAF H GALLE PR
Citation: M. Volkmann et al., P53 OVEREXPRESSION IS FREQUENT IN EUROPEAN HEPATOCELLULAR-CARCINOMA AND LARGELY INDEPENDENT OF THE CODON-249 HOT-SPOT MUTATION, Oncogene, 9(1), 1994, pp. 195-204
DETECTION OF MDM2 PROTEIN IN HEPATOCELLULAR CARCINOMAS WITH INCREASEDP53 LEVELS BUT WITH AN INTACT P53 GENE
Authors: ZENTGRAF H STREMMEL W VOLKMANN M GALLE PR
Citation: H. Zentgraf et al., DETECTION OF MDM2 PROTEIN IN HEPATOCELLULAR CARCINOMAS WITH INCREASEDP53 LEVELS BUT WITH AN INTACT P53 GENE, Hepatology, 20(4), 1994, pp. 10000378-10000378
CLINICAL IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE
Authors: MULLER M VOLKMANN M ZENTGRAF H GALLE PR
Citation: M. Muller et al., CLINICAL IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE, The New England journal of medicine, 330(12), 1994, pp. 865-865
GENETIC-HETEROGENEITY OF HEPATOCELLULAR-CARCINOMA
Authors: UNSAL H YAKICIER C MARCAIS C KEW M VOLKMANN M ZENTGRAF H ISSELBACHER KJ OZTURK M
Citation: H. Unsal et al., GENETIC-HETEROGENEITY OF HEPATOCELLULAR-CARCINOMA, Proceedings of the National Academy of Sciences of the United Statesof America, 91(2), 1994, pp. 822-826
ANTIBODIES TO MUTANT P53 PROTEIN IN HEPATOCELLULAR-CARCINOMA (HCC) - A NEW DIAGNOSTIC-TEST
Authors: RYDER SD RIZZI PM VOLKMANN M ZENTRAF H NAOUMOV N WILLIAMS R
Citation: Sd. Ryder et al., ANTIBODIES TO MUTANT P53 PROTEIN IN HEPATOCELLULAR-CARCINOMA (HCC) - A NEW DIAGNOSTIC-TEST, Gastroenterology, 106(4), 1994, pp. 10000435-10000435
IN-VITRO EXPERIMENTAL-INFECTION OF PRIMARY HUMAN HEPATOCYTES WITH HEPATITIS-B VIRUS
Authors: GALLE PR HAGELSTEIN J KOMMERELL B VOLKMANN M SCHRANZ P ZENTGRAF H
Citation: Pr. Galle et al., IN-VITRO EXPERIMENTAL-INFECTION OF PRIMARY HUMAN HEPATOCYTES WITH HEPATITIS-B VIRUS, Gastroenterology, 106(3), 1994, pp. 664-673
P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO TREATMENT WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS
Authors: DOHNER H FISCHER K STILGENBAUER S BENTZ M HANSEN K WEISS G BENNER A SCHLENK R COY J VOLKMANN M GALLE PR HUNSTEIN W LICHTER P
Citation: H. Dohner et al., P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO TREATMENT WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS, Blood, 84(10), 1994, pp. 10000439-10000439
COLOCALIZATION OF THE TUMOR-SUPPRESSOR PROTEIN P53 AND HUMAN PAPILLOMAVIRUS-E6 PROTEIN IN HUMAN CERVICAL-CARCINOMA CELL-LINES
Authors: LIANG XH VOLKMANN M KLEIN R HERMAN B LOCKETT SJ
Citation: Xh. Liang et al., COLOCALIZATION OF THE TUMOR-SUPPRESSOR PROTEIN P53 AND HUMAN PAPILLOMAVIRUS-E6 PROTEIN IN HUMAN CERVICAL-CARCINOMA CELL-LINES, Oncogene, 8(10), 1993, pp. 2645-2652
P53 OVEREXPRESSION IN HCC IS CORRELATED WITH THE PROLIFERATIVE ACTIVITY BUT NOT WITH EGF-R EXPRESSION OF THE TUMORS
Authors: HOFMANN WJ VOLKMANN M HAAG D OTTO G GALLE PR
Citation: Wj. Hofmann et al., P53 OVEREXPRESSION IN HCC IS CORRELATED WITH THE PROLIFERATIVE ACTIVITY BUT NOT WITH EGF-R EXPRESSION OF THE TUMORS, Hepatology, 18(4), 1993, pp. 10000185-10000185
ANTI-P53 SERUM ANTIBODIES IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA AND GI-TRACT TUMORS - CLINICAL RELEVANCE AND DIAGNOSTIC USEFULNESS
Authors: MUELLER M MEYER M VOLKMANN M RATH U KOMMERELL B GALLE PR
Citation: M. Mueller et al., ANTI-P53 SERUM ANTIBODIES IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA AND GI-TRACT TUMORS - CLINICAL RELEVANCE AND DIAGNOSTIC USEFULNESS, Hepatology, 18(4), 1993, pp. 10000190-10000190
P53 IN EUROPEAN HEPATOCELLULAR-CARCINOMA - GENOMIC ALTERATIONS ASSOCIATED WITH INCREASED STEADY-STATE LEVELS AND HETEROGENOUS FUNCTIONAL-CHARACTERISTICS IN-VITRO
Authors: VOLKMANN M HOFMANN WJ MULLER M KLEIN R WILLEMANN B ZENTGRAF H RATH U GALLE PR
Citation: M. Volkmann et al., P53 IN EUROPEAN HEPATOCELLULAR-CARCINOMA - GENOMIC ALTERATIONS ASSOCIATED WITH INCREASED STEADY-STATE LEVELS AND HETEROGENOUS FUNCTIONAL-CHARACTERISTICS IN-VITRO, Hepatology, 18(4), 1993, pp. 10000196-10000196
Risultati: 1-25 | 26-27